1. Home
  2. HXHX vs INBS Comparison

HXHX vs INBS Comparison

Compare HXHX & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HXHX

Haoxin Holdings Limited Class A Ordinary Shares

HOLD

Current Price

$0.45

Market Cap

7.1M

Sector

Industrials

ML Signal

HOLD

INBS

Intelligent Bio Solutions Inc.

HOLD

Current Price

$3.62

Market Cap

6.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HXHX
INBS
Founded
2003
2016
Country
China
United States
Employees
85
N/A
Industry
Trucking Freight/Courier Services
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1M
6.4M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
HXHX
INBS
Price
$0.45
$3.62
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
96.0K
80.2K
Earning Date
01-01-0001
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
68.65
EPS
N/A
N/A
Revenue
N/A
$1,980,484.00
Revenue This Year
N/A
$778.48
Revenue Next Year
N/A
N/A
P/E Ratio
$1.96
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$0.54
52 Week High
$2.15
$24.90

Technical Indicators

Market Signals
Indicator
HXHX
INBS
Relative Strength Index (RSI) 44.12 30.61
Support Level $0.34 $1.49
Resistance Level $0.55 $7.25
Average True Range (ATR) 0.03 0.36
MACD -0.00 0.10
Stochastic Oscillator 25.85 2.03

Price Performance

Historical Comparison
HXHX
INBS

About HXHX Haoxin Holdings Limited Class A Ordinary Shares

Haoxin Holdings Ltd is engaged in the logistics industry, including container provider of temperature-controlled truckload service and urban delivery services in China, freight forwarding, cold chain transportation and other businesses. The types of goods involved are all kinds of new energy materials that require low temperature, heat preservation, and constant temperature, electronic products, medicines, meat, fruits, vegetables and others.

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.

Share on Social Networks: